DOCSLIB.ORG

116588NCJRS.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
116588NCJRS.Pdf If you have issues viewing or accessing this file contact us at NCJRS.gov. " "'- u.s. Department of Justice Federal Bureau of Investigation PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON FORENSIC IMMUNOLOGY FBI ACADEMY QUANTICO, VIRGINIA JUNE 23-26, 1986 Proceedings of the International Symposium on Forensic Immunology co 00 L() \0 u, r-l O§ r-l Ql C. If) 05~ Ql 0- 0 ~ o~ Ql E C/) Ql >. c:0 If) C/) ~ * ....,a: () a: z Ql '*02 Ql iii :5 ...... ....,::> a Ql {ij "...:0- Ql c: !!lc: °E ::>;: B 00 {ij c: 0 ~I::> z~ "e CD ~~ :5 .... ~o- S 1::C: Lt .~ Host Laboratory Division Federal Bureau of Investigation June 23-26, 1986 Forensic Science Research and Training Center FBI Academy Quantico, Virginia NOTICE This publication was prepared by the U. S. Government. Neither the U. S. Government nor the U. S. Department of Justice nor any of their employees makes any warranty, express or implied, or assumes any legal liability or responsibility for the accuracy, completeness or usefulness of any information, apparatus, product or process disclosed, or represents that in use would not infringe privately owned rights. Reference herein to any specific commercial product, process or service by trade name, mark, manufacturer or otherwise does not necessarily constitute or imply its endorsement, recommendation or favoring by the U. S. Government or any agency thereof. The views and opinions of authors expressed herein do not necessarily state or reflect those of the U. S. Government or any agency thereof. Published by: The Laboratory Division Roger T. Castonguay Assistant Director in Charge Federal Bureau of Investigation U. S. Department of Justice Washington, D.C. 20535 International Standard Book Number 0-932115-07-1 Library of Congress Number 87-619829 Printed by the U.S. Government Printing Office Cover: Aerial photograph of the FBI Academy by George February. For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, D.C. 20402 FOREWORD On June 23-26, 1986, the FBI Laboratory hosted an "International Symposium on Forensic Immunology." The symposium was held at the Forensic Science Research and Training Center, Quantico, Virginia, and there were 175 scientists in attendance from industry, university and government laboratories in the United States, Canada, the Federal Republic of Germany, France, Italy, Japan and the United Kingdom. Plenary sessions were held on topics such as the immunologic basis for species differentiation, the biochemical genetics of the ABO and Lewis cellular and soluble antigens, inhibition-elution and mixed agglutination methods, ELISA methodology, quality control of immunology reagents and laboratory safety. In addition, there were short oral and poster presentations and panel discussions on relevant topics. The symposium provided an exchange of ide!lS which, it is hoped, will generate future research and strengthen the scientific merit of the forensic applications of immunology. Consequently, I believe the objectives of this symposium were met by gathering together respected scientists to discuss immunology and forensic applica­ tions. On behalf of the FBI, I would like to thank all those who participated in the symposium. ROGER T. CASTONGUAY Assistant Director-in-Charge FBI Laboratory iii ~----~--~~~~~---.--------------- Program Organizing Committee BARRY L. BROWN JOSEPH J. ERRERA FBI Laboratory }?BI Laboratory F. SAMUEL BAECHTEL JAMES J. KEARNEY FBI Laboratory FBI Laboratory ROBERT SPALDING FBI Laboratory Session Moderators BARRY L. BROWN RANDALL S. MURCH FBI Laboratory FBI Laboratory JOSEPH J. ERRERA MONICA SAENGER FBI Laboratory MOSES SCHANFIELD JAMES J. KEARNEY Allotype Testing Institute FBI Laboratory ROBERT SPALDING ROBERT E. GAENSSLEN FBI Laboratory University of New Haven DAVID J. WERRETT Central Research Establishment v Contents FOREWORD......................................................................................................... iii SECTION I - LECTURES Inhibition, Elution and Mixed Agglutination................................................................... 3 Patrick J. Lincoln Discussion............................................................................................... 12 Immunologic Basis for Species Differentiation............................ ...................................... 15 David C. Benjamin, John C. Herr and Michael P. Woodward Discussion ............................................................................................... 22 The Biochemical Genetics of ABH and Lewis Cellular Antigens.......................................... 23 Rafael Oriol Discussion ............................................................................................... 35 Biochemical Genetics and Methodology for the Forensic Analysis of HLA Antigens.................. 37 Pamela J. Newall Discussion ............................................................................................... 51 The Biochemical Genetics and Methodology for the Analysis of the Gm and Km Antigens........ 53 Graham B. Divall Discussion............................................................................................... 61 The Biochemistry, Genetics and Applications of the ABO and Lewis Soluble Antigens .............. 63 David J. Werrett and B. G. Lang Discussion ............................................................................................... 80 Applications and Implications of ELISAs in Forensic Immunology ....................................... 83 Steven M Fletcher Discussion ............................................................................................... 90 Quality Control of Immunology Reagents....................................................................... 93 Gregory C. Kennedy Safety in the Forensic Immunology Laboratory................................................................ 101 Walter W. Bond Discussion............................................................................................... 108 Perspectives on the Future of Forensic Immunology ...................................... ,.................. 111 George F. Sensabaugh SECTION II - EXTENDED ABSTRACTS Detection of Semen Blood Group Substances by Adsorption-Inhibition, Adsorption-Elution and Enzyme Linked Immunosorbent Assay....................................................................... 119 J. L. Mudd Phenotyping of ABO Subgroups from Cloth Threads........... ............ ................................. 121 J. R. Melvin, Jr., T. L. Wolson, D. L. Keagle and L. R. Simson Two-Dimensional Adsorption-Inhibition.......................................................................... 125 H. C. Lee, R. E. Gaensslen, E. M Pagliaro and B. Novitch ABH Typing of Urine by a Two-Dimensional Adsorption-Inhibition Procedure... ..................... 127 H. C. Lee, R. E. Gaensslen and E. M Pagliaro ABO Typing of Dried Bloodstains Mixed With Body Fluids by Methanol Extraction................ 129 M A. Tahir and D. J. Czech Separation of Blood Group Substances ABH and Lewis in Mixtures of Body Fluids................. 131 S. L. Bolton and J. W. Thorpe ABH Blood Group Substance Levels in Matched Body Fluid Stains: A Preliminary Investigation....................................................................................................... 135 T. F. Spear and S. A. Binkley vii ABH and Lewis Typing: Application to f ,lected Problems in Mixtures of Semen and Vaginal Secretions. 137 M. M Gibbons, E. T. Blake and G. F. Sensabaugh Levels and Distribution of ABH and Lewis Blood Group Substances in Vaginal Secretions......... 139 M M Gibbons, E. T. Blake and G. F. Sensabaugh Interpretation of Serologic Results................................................................................ 141 H. C. Lee and R. E. Gaensslen Application of the Immunohistochemical Technique to the ABO Blood Grouping of Human Head Hair......................................................................................................... 145 S. Miyasaka and S. Seta Use of an Enzyme Linked Immunosorbent Assay for the Detection of P30 in Questioned Semen Stains...................................................................................................... 147 F. S. Baechtel, J. C. Jung and L. D. Terrell Purification of Seminal Vesicle Specific Antigen by Immunoaffinity Chromatography on Bound Monoclonal Antibody MHS-5 .................................................................................. 149 J. C. Herr, R. S. McGee and D. J. Conklin ELISA Assay for Human Semen Identification Using a Monoclonal Antibody to a Seminal Vesicle Specific Antigen......................................................................................... 153 J. C. Herr and M P. Woodward Enzyme Immunoassay for M Antigen in Bloodstains................................. .............. .......... 157 G. F. Sensabaugh, R. J. Kochenburger and L. M Calandro Determination of ABO Blood Groups from Human Bloodstains and Body Fluid Stains with Mouse Monoclonal Antibodies................................................................................. 159 H. Mukoyama and 1. Sakai The Forensic Application of Anti-A and Anti-B (Murine Monoclonal Blend) Bioclone™ Antisera to the Examination of Blood and Body Fluids in the Crime Laboratory............................. 161 T. L. Wolson and J. R. Melvin, Jr. Use of Monoclonal Antibodies Against ABO(H) Antigens: Detection of Soluble Blood Group Substances in Semen............................................................................................
Load more

Recommended publications
  • CCR7 Antibody (Y59) NB110-55680
    Product Datasheet CCR7 Antibody (Y59) NB110-55680 Unit Size: 0.1 ml Store at -20C. Avoid freeze-thaw cycles. Publications: 9 Protocols, Publications, Related Products, Reviews, Research Tools and Images at: www.novusbio.com/NB110-55680 Updated 5/28/2019 v.20.1 Earn rewards for product reviews and publications. Submit a publication at www.novusbio.com/publications Submit a review at www.novusbio.com/reviews/destination/NB110-55680 Page 1 of 6 v.20.1 Updated 5/28/2019 NB110-55680 CCR7 Antibody (Y59) Product Information Unit Size 0.1 ml Concentration This product is unpurified. The exact concentration of antibody is not quantifiable. Storage Store at -20C. Avoid freeze-thaw cycles. Clonality Monoclonal Clone Y59 Preservative 0.01% Sodium Azide Isotype IgG Purity Tissue culture supernatant Buffer 49% PBS, 0.05% BSA and 50% Glycerol Target Molecular Weight 45 kDa Product Description Host Rabbit Gene ID 1236 Gene Symbol CCR7 Species Human, Mouse, Rat, Monkey Reactivity Notes May cross reacts with Rhesus monkey. Specificity/Sensitivity The antibody does not cross-react with other G-protein coupled receptor 1 family members. Immunogen A synthetic peptide corresponding to residues in N-terminal extracellular domain of human CKR7 was used as immunogen. Notes Produced using Abcam's RabMab® technology. RabMab® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487. Product Application Details Applications Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Frozen, Immunohistochemistry- Paraffin, Immunoprecipitation, Flow Cytometry (Negative) Recommended Dilutions Western Blot 1:1000-10000, Immunohistochemistry 1:10-1:500, Immunocytochemistry/Immunofluorescence 1:250, Immunoprecipitation 1:10, Immunohistochemistry-Paraffin 1:250, Immunohistochemistry-Frozen 1:250, Flow Cytometry (Negative) Application Notes This product is useful for: Western Blot, Immunohistochemistry-Paraffin, Immunocytochemistry, Immunoprecipitation.
    [Show full text]
  • Section 8: Hematology CHAPTER 47: ANEMIA
    Section 8: Hematology CHAPTER 47: ANEMIA Q.1. A 56-year-old man presents with symptoms of severe dyspnea on exertion and fatigue. His laboratory values are as follows: Hemoglobin 6.0 g/dL (normal: 12–15 g/dL) Hematocrit 18% (normal: 36%–46%) RBC count 2 million/L (normal: 4–5.2 million/L) Reticulocyte count 3% (normal: 0.5%–1.5%) Which of the following caused this man’s anemia? A. Decreased red cell production B. Increased red cell destruction C. Acute blood loss (hemorrhage) D. There is insufficient information to make a determination Answer: A. This man presents with anemia and an elevated reticulocyte count which seems to suggest a hemolytic process. His reticulocyte count, however, has not been corrected for the degree of anemia he displays. This can be done by calculating his corrected reticulocyte count ([3% × (18%/45%)] = 1.2%), which is less than 2 and thus suggestive of a hypoproliferative process (decreased red cell production). Q.2. A 25-year-old man with pancytopenia undergoes bone marrow aspiration and biopsy, which reveals profound hypocellularity and virtual absence of hematopoietic cells. Cytogenetic analysis of the bone marrow does not reveal any abnormalities. Despite red blood cell and platelet transfusions, his pancytopenia worsens. Histocompatibility testing of his only sister fails to reveal a match. What would be the most appropriate course of therapy? A. Antithymocyte globulin, cyclosporine, and prednisone B. Prednisone alone C. Supportive therapy with chronic blood and platelet transfusions only D. Methotrexate and prednisone E. Bone marrow transplant Answer: A. Although supportive care with transfusions is necessary for treating this patient with aplastic anemia, most cases are not self-limited.
    [Show full text]
  • Memoranaurns by the Participants in Signes Par Les Partici- I the Meeting
    Memoranda are state- Les Memorandums ments concerning the exposent les conclu- /e , conclusions or recom- sions et recomman- M e mmooranrantedaa mendations of certain dations de certaines / a t w / /WHO scientific meet- /reunions scientifiques ings; they are signed de /'OMS; ils sont Memoranaurns by the participants in signes par les partici- I the meeting. pants a ces reunions. Bulletin ofthe World Health Organization, 62 (2): 217-227 (1984) © World Health Organization 1984 Immunodiagnosis simplified: Memorandum from a WHO Meeting* Technologies suitable for the development ofsimplified immunodiagnostic tests were reviewed by a Working Group of the WHO Advisory Committee on Medical Research in Geneva in June 1983. They included agglutination tests and use ofartificialparticles coated with immunoglobulins, direct visual detection of antigen-antibody reactions, enzyme- immunoassays, and immunofluorescence and fluoroimmunoassays. The use of mono- clonal antibodies,in immunodiagnosis and of DNA /RNA probes to identify viruses was also discussed in detail. The needfor applicability of these tests at three levels, i.e., field conditions (or primary health care level), local laboratories, and central laboratories, was discussed and their use at thefield level was emphasized. Classical serological techniques have been used for All these tests can be carried out in laboratories that a long time for diagnostic purposes, e.g., for con- are equipped with basic instruments as well as special- firmation of clinical diagnoses, epidemiological ized apparatus (e.g., gamma counters for RIA, ultra- studies, testing of blood donors, etc. Some of these violet microscopes for IMF, etc.), which are usually techniques have been standardized to a high degree of available only in the larger, central laboratories.
    [Show full text]
  • A Rapid and Quantitative D-Dimer Assay in Whole Blood and Plasma on the Point-Of-Care PATHFAST Analyzer ARTICLE in PRESS
    MODEL 6 TR-03106; No of Pages 7 ARTICLE IN PRESS Thrombosis Research (2007) xx, xxx–xxx intl.elsevierhealth.com/journals/thre REGULAR ARTICLE A rapid and quantitative D-Dimer assay in whole blood and plasma on the point-of-care PATHFAST analyzer Teruko Fukuda a,⁎, Hidetoshi Kasai b, Takeo Kusano b, Chisato Shimazu b, Kazuo Kawasugi c, Yukihisa Miyazawa b a Department of Clinical Laboratory Medicine, Teikyo University School of Medical Technology, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan b Department of Central Clinical Laboratory, Teikyo University Hospital, Japan c Department of Internal Medicine, Teikyo University School of Medicine, Japan Received 11 July 2006; received in revised form 7 December 2006; accepted 28 December 2006 KEYWORDS Abstract The objective of this study was to evaluate the accuracy indices of the new D-Dimer; rapid and quantitative PATHFAST D-Dimer assay in patients with clinically suspected Deep-vein thrombosis; deep-vein thrombosis (DVT). Eighty two consecutive patients (34% DVT, 66% non-DVT) Point-of-care testing; with suspected DVT of a lower limb were tested with the D-Dimer assay with a Chemiluminescent PATHFAST analyzer. The diagnostic value of the PATHFAST D-Dimer assay (which is immunoassay based on the principle of a chemiluminescent enzyme immunoassay) for DVT was evaluated with pre-test clinical probability, compression ultrasonography (CUS). Furthermore, each patient underwent contrast venography and computed tomogra- phy, if necessary. The sensitivity and specificity of the D-Dimer assay using 0.570 μg/ mL FEU as a clinical cut-off value was found to be 100% and 63.2%, respectively, for the diagnosis of DVT, with a positive predictive value (PPV) and negative predictive value (NPV) of 66.7% and 100%, respectively.
    [Show full text]
  • Cytokine Immunocytochemistry Fax (65) 860-1590 Fax (49) 40 531 58 92 Fax (81) 3 541-381-55 E-Mail: [email protected]
    PharMingen International United States Canada PharMingen Europe Japan PharMingen Canada Tel 619-812-8800 Asia Pacific Becton Dickinson GmbH Nippon Becton Dickinson Toll-Free 1-888-259-0187 Orders 1-800-848-6227 BD Singapore HQ PharMingen Europe Company Ltd. Tel 905-542-8028 Tech Service 1-800-825-5832 Tel (65) 860-1478 Tel (49) 40 532 84 48 0 Tel (81) 3 541-382-51 Fax 905-542-9391 Fax 619-812-8888 Cytokine Immunocytochemistry Fax (65) 860-1590 Fax (49) 40 531 58 92 Fax (81) 3 541-381-55 e-mail: [email protected] http://www.pharmingen.com Africa Germany Latin/South America Spain Becton Dickinson Worldwide Inc. Becton Dickinson GmbH BDIS (USA) Becton Dickinson S.A. Reagents and Techniques Tel (254) 2 449 608 HQ PharMingen Europe Tel (408) 954-2157 Tel (34) 91 848 8100 Fax (254) 2 449 619 Tel (49) 40 532 84 48 0 Fax (408) 526-1804 Fax (34) 91 848 8105 Fax (49) 40 531 58 92 Orders for Microscopic Analysis of Cytokine-Producing Cells Australia Malaysia Tel (34) 91 848 8182 Becton Dickinson Pty Ltd Greece Becton Dickinson Sdn Bhd Fax (34) 91 848 8104 Tel (612) 9978-6800 Becton Dickinson Hellas S.A. Tel (03) 7571323 Fax (612) 9978-6850 Tel (30) 1 9407741 Fax (03) 7571153 Sweden Fax (30) 1 9407740 Becton Dickinson AB Austria Mexico Tel (46) 8 775 51 00 Becton Dickinson GmbH Hong Kong Becton Dickinson de Mexico Fax (46) 8 645 08 08 HQ PharMingen Europe Becton Dickinson Asia Ltd Tel (52-5) 237-12-98 Tel (49) 40 532 84 48 0 Tel (852) 2572-8668 Fax (52-5) 237-12-93 Switzerland Fax (49) 40 531 58 92 Fax (852) 2520-1837 Becton Dickinson GmbH Middle East HQ PharMingen Europe Belgium Hungary Becton Dickinson Tel (41) 06 1-385 4422 Becton Dickinson Benelux N.V.
    [Show full text]
  • Introduction to Hematological Assessment (PDF)
    UPDATED 01/2021 Introduction to Hematological Assessment Objectives After completing this lesson, you will be able to: • State the main purposes of a hematological assessment. • Explain the procedures for collecting and processing a blood sample. • Understand the importance of hand washing. • Understand the importance of preventing blood borne pathogen transmission. • Describe and follow the hemoglobin test procedure using the Hemocue Hemoglobin Analyzer. Overview The most common form of nutritional deficiency is “iron deficiency”. It is observed more frequently among children and women of childbearing age (particularly pregnant women). Iron deficiency can result in developmental delays and behavioral disturbance in children, as well as increased risk for a preterm delivery in pregnant women. Iron status can be determined using several different types of laboratory tests. The two tests most commonly used to screen for iron deficiency are hemoglobin (Hgb) concentration and hematocrit (Hct). Proper screening for iron deficiency requires sound laboratory methods and procedures. Often, CPAs will hear the following questions: “Do you have to stick my finger? What does this have to do with my WIC foods anyway? Will it hurt?” For most of us, the thought of having blood taken, even from a finger, is not pleasant. However, evaluating the results of a blood test is a part of screening for nutritional risk. Why Does WIC Require Hematological Assessment? WIC requires that each applicant be screened for risk of a medical condition known as iron deficiency anemia. Anemia is a condition of the blood in which the amount of hemoglobin falls below a level considered desirable for good health.
    [Show full text]
  • Your Blood Cells
    Page 1 of 2 Original Date The Johns Hopkins Hospital Patient Information 12/00 Oncology ReviseD/ RevieweD 6/14 Your Blood Cells Where are Blood cells are made in the bone marrow. The bone marrow blood cells is a liquid that looks like blood. It is found in several places of made? the body, such as your hips, chest bone and the middle part of your arm and leg bones. What types of • The three main types of blood cells are the red blood cells, blood cells do the white blood cells and the platelets. I have? • Red blood cells carry oxygen to all parts of the body. The normal hematocrit (or percentage of red blood cells in the blood) is 41-53%. Anemia means low red blood cells. • White blood cells fight infection. The normal white blood cell count is 4.5-11 (K/cu mm). The most important white blood cell to fight infection is the neutrophil. Forty to seventy percent (40-70%) of your white blood cells should be neutrophils. Neutropenia means your neutrophils are low, or less than 40%. • Platelets help your blood to clot and stop bleeding. The normal platelet count is 150-350 (K/cu mm). Thrombocytopenia means low platelets. How do you Your blood cells are measured by a test called the Complete measure my Blood Count (CBC) or Heme 8/Diff. You may want to keep track blood cells? of your blood counts on the back of this sheet. What When your blood counts are low, you may become anemic, get happens infections and bleed or bruise easier.
    [Show full text]
  • Blood Donor Information
    Blood Donor Information Thank you for coming to donate blood. We are Did you know that some causes sorry that we cannot accept you as a donor today of anemia are invisible? because your hematocrit level was too low. You may not know you have bleeding from We care about your health and want to help you your digestive tract. This can be a result of: understand what having a low hematocrit level means.You are not alone, having a low hematocrit • Stomach ulcers level is the most frequent cause for not being able • Growths in intestines (polyps) to donate blood. You may return to donate when • Colon cancer your hematocrit level has increased and you can • Certain medications help immediately by asking your friends, family • Other diseases of the digestive tract and/or coworkers to donate. There are several Anemia is often the first symptom of these simple ways to improve your hematocrit level. conditions so it should be taken seriously. If you feel You may be eligible to donate another time. you don’t fit in any of the previous categories, What is Hematocrit? or just want to rule out these possibilities, make an appointment with your physician without delay. Blood is made up of red blood cells, white blood cells, platelets, and plasma. Hematocrit is the percentage of blood You should see your doctor if your volume that is red blood cells. Red blood cells contain hematocrit is low and you: hemoglobin which carries oxygen to all the cells in the body. • donate less than three times per year, Why do we test potential blood • are a non-menstruating woman of any donors for hematocrit levels? age with a hematocrit below 36%, Hematocrit is measured prior to each donation as part of • a man with a hematocrit less than 38%, and donor screening.
    [Show full text]
  • AG 39: Immunofluorescence Assays (PDF)
    ibidi Application Guide Immunofluorescence Assays The Principle of Immunofluorescence Immunofluorescence Applied: Assays . 2 Experimental Examples . 13 Rat Hippocampal Neuron and Astrocyte Staining 14 Immunofluorescence Staining: Visualization of Endothelial Cell Junctions . 13 A Typical Workflow . 3 Immunostaining of Rat Dorsal Root Ganglionic Experiment Planning and Sample Preparation . 4 Cells and Schwann Cells . 13 Sample Fixation . 4 Adherens Junctions and Actin Cytoskeleton of Cell Permeabilization . 5 HUVECs Under Flow . 14 Blocking . 5 Mitochondria Staining of MDCK cells . 14 Primary Antibody Incubation . 5 Focal Adhesions of Differentiated Mouse Fibroblasts on an Elastic Surface . 15 Secondary Antibody Incubation . 6 Counterstain and Mounting . 7 Microscopy . 7 Troubleshooting . 8 Selected Publications Immunofluorescence C. Xu, et al. NPTX2 promotes colorectal cancer growth and liver With the ibidi Chambers . 9 metastasis by the activation of the canonical Wnt/beta-catenin pathway via FZD6. Cell Death & Disease, 2019, 10.1038/s41419- Comparison of Immunocytochemistry Protocols . 10 019-1467-7 Chambered Coverslips . 11 read abstract Kobayashi, T., et al. Principles of early human development and Channel Slides . 11 germ cell program from conserved model systems. Nature, Chamber Slides . 12 2017, 10.1038/nature22812 read abstract H. Tada et al. Porphyromonas gingivalis Gingipain-Dependently Enhances IL-33 Production in Human Gingival Epithelial Cells. PloS one, 2016, 10.1371/journal.pone.0152794 read abstract N. J. Foy, M. Akhrymuk, A. V. Shustov, E. I. Frolova and I. Frolov. Hypervariable Domain of Nonstructural Protein nsP3 of Venezuelan Equine Encephalitis Virus Determines Cell-Specific Mode of Virus Replication. Journal of Virology, 2013, 10.1128/ jvi.00720-13 read abstract .com The Principle of Immunofluorescence Assays Immunofluorescence (IF) is a powerful approach for getting insight into cellular structures and processes using microscopy .
    [Show full text]
  • Understanding Blood Tests
    PATIENT EDUCATION patienteducation.osumc.edu Understanding Blood Tests Your heart pumps the blood in your body through a system of blood vessels. Blood delivers oxygen and nutrients to all parts of the body. It also carries away waste products. Blood is made up of red blood cells, white blood cells, platelets and a clear fluid called plasma. There are also other parts in the blood such as electrolytes, proteins, fats, sugar, and hormones. Your doctor can check for certain diseases and conditions by doing blood tests. A small sample of blood is taken and sent to the lab. The test results help your doctor: • Check your general health • See how well your body organs are working • Find health problems, diseases and disorders • Watch the body’s response to medicines and treatments Common blood tests include a Complete Blood Count (CBC) with differential, and a Comprehensive Metabolic Panel (CMP). Note: Some health problems may require ongoing monitoring or repeat testing. It is important to know that normal range values can vary from laboratory to laboratory. Talk with your doctor if you have questions about your test results. Complete Blood Count (CBC) A CBC shows the number of white and red blood cells, hematocrit, hemoglobin and platelets in your blood. This test helps your doctor look for signs of anemia, infection, bleeding problems or certain diseases and disorders. This handout is for informational purposes only. Talk with your doctor or health care team if you have any questions about your care. © January 9, 2018. The Ohio State University Comprehensive Cancer Center – Arthur G.
    [Show full text]
  • TITLE: Complete Blood Count (CBC) Basics PRESENTER: Sarah Drawz and Michael Linden
    TITLE: Complete Blood Count (CBC) Basics PRESENTER: Sarah Drawz and Michael Linden Slide 1: Good afternoon, my name is Dr. Michael Linden. I am the Director of Hematopathology at the University of Minnesota in Minneapolis, MN. With me is Dr. Sarah Drawz, who is a Hematopathology Fellow, also at the University of Minnesota. I would like to introduce Dr. Sarah Drawz, who will be beginning our presentation as part of this AACC Pearl of Laboratory Medicine on “Complete Blood Count (CBC) Basics.” Slide 2: The complete blood count (CBC) is an important initial test in the evaluation of a patient’s hematologic function. The CBC is performed on whole blood, which is composed of two primary components: plasma and cells. The plasma fraction contains mostly water, numerous proteins, electrolytes, and clotting factors. The cellular component of blood is comprised of the three major categories of blood cells: red blood cells (RBCs), white blood cells (WBCs), and platelets. The CBC test yields numbers of these main types of cells, but also additional information, such as the volume of red blood cells, or hematocrit, and quantity of different types of white blood cells, the differential. Slide 3: CBCs are collected from patients in both inpatient and outpatient settings. Generally, 3 to 10 ml of whole blood are drawn from a peripheral vein directly into a tube. The tube must contain anticoagulant to prevent clots from obscuring the CBC analysis. Various types of anticoagulants are used including ethylenediaminetetraacetic acid (EDTA), heparin, and citrate. The most common anticoagulant used for the CBC is EDTA.
    [Show full text]
  • Laboratory Analysis of the Immune Response 859
    Chapter 20 | Laboratory Analysis of the Immune Response 859 Chapter 20 Laboratory Analysis of the Immune Response Figure 20.1 Lab-on-a-chip technology allows immunological assays to be miniaturized so tests can be done rapidly with minimum quantities of expensive reagents. The chips contain tiny flow tubes to allow movement of fluids by capillary action, reactions sites with embedded reagents, and data output through electronic sensors. (credit: modification of work by Maggie Bartlett, NHGRI) Chapter Outline 20.1 Polyclonal and Monoclonal Antibody Production 20.2 Detecting Antigen-Antibody Complexes 20.3 Agglutination Assays 20.4 EIAs and ELISAs 20.5 Fluorescent Antibody Techniques Introduction Many laboratory tests are designed to confirm a presumptive diagnosis by detecting antibodies specific to a suspected pathogen. Unfortunately, many such tests are time-consuming and expensive. That is now changing, however, with the development of new, miniaturized technologies that are fast and inexpensive. For example, researchers at Columbia University are developing a “lab-on-a-chip” technology that will test a single drop of blood for 15 different infectious diseases, including HIV and syphilis, in a matter of minutes.[1] The blood is pulled through tiny capillaries into reaction chambers where the patient’s antibodies mix with reagents. A chip reader that attaches to a cell phone analyzes the results and sends them to the patient’s healthcare provider. Currently the device is being field tested in Rwanda to check pregnant women for chronic diseases. Researchers estimate that the chip readers will sell for about $100 and individual chips for $1.[2] 1.
    [Show full text]